GOSS Stock Analysis: Buy, Sell, or Hold?
GOSS - Gossamer Bio, Inc. Common Stock
$0.14
-0.01 (-4.56%)
▼
5d:
-20.05%
30d:
-19.53%
90d:
-63.6%
WAIT
LOW Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 04, 2026
8d
Get Alerted When GOSS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GOSS is down 20.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GOSS is down 20.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GOSS is currently trading at $0.14, which is considered oversold relative to its 30-day fair value range of $0.15 to $0.18.
Technical Outlook: Technically, GOSS is in a strong downtrend. Immediate support is located at $0.11, while resistance sits at $0.18. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.86 (+2735.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GOSS is in a strong downtrend. Immediate support is located at $0.11, while resistance sits at $0.18. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.86 (+2735.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.15 -
$0.18
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding GOSS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 2735.3% below Wall St target ($3.86)
- WARNING: Recommendation downgraded due to -20.0% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.15 -
$0.18
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.11
Resistance Level
$0.18
Current Trend
Strong Downtrend
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.47
Wall Street Target
$3.86
(+2735.3%)
Revenue Growth (YoY)
71.5%
Share & Embed Analysis
Last updated: July 26, 2026 4:42 AM ET
Data refreshes hourly during market hours. Next update: 5:42 AM
Data refreshes hourly during market hours. Next update: 5:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GOSS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$415 | 49 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$280 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 54 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 51 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$114 | 53 HOLD |
Advanced GOSS Option Strategies
Professional options setups generated by AI based on today's GOSS price and gamma walls.
